Sakamoto K, Wang W, Tian R (2014) Muta-
tion in the gamma2-subunit of AMP-activated
protein kinase stimulates cardiomyocyte prolif-
eration and hypertrophy independent of glyco-
gen storage. Circ Res 114(6):966–975.
https://doi.org/10.1161/circresaha.114.302
364- Folmes KD, Chan AY, Koonen DP, Pulinilk-
unnil TC, Baczko I, Hunter BE, Thorn S,
Allard MF, Roberts R, Gollob MH, Light PE,
Dyck JR (2009) Distinct early signaling events
resulting from the expression of the PRKAG2
R302Q mutant of AMPK contribute to
increased myocardial glycogen. Circ Cardio-
vasc Genet 2(5):457–466. https://doi.org/
10.1161/CIRCGENETICS.108.834564.
CIRCGENETICS.108.834564 [pii] - Xiao B, Heath R, Saiu P, Leiper FC, Leone P,
Jing C, Walker PA, Haire L, Eccleston JF, Davis
CT, Martin SR, Carling D, Gamblin SJ (2007)
Structural basis for AMP binding to mamma-
lian AMP-activated protein kinase. Nature 449
(7161):496–500. https://doi.org/10.1038/
nature06161. nature06161 [pii] - Hamilton SR, Stapleton D, O’Donnell JB Jr,
Kung JT, Dalal SR, Kemp BE, Witters LA
(2001) An activating mutation in the gamma1
subunit of the AMP-activated protein kinase.
FEBS Lett 500(3):163–168 - Barnes BR, Marklund S, Steiler TL, Walter M,
Hjalm G, Amarger V, Mahlapuu M, Leng Y,
Johansson C, Galuska D, Lindgren K,
Abrink M, Stapleton D, Zierath JR, Andersson
L (2004) The 5^0 -AMP-activated protein kinase
gamma3 isoform has a key role in carbohydrate
and lipid metabolism in glycolytic skeletal mus-
cle. J Biol Chem 279(37):38441–38447.
https://doi.org/10.1074/jbc.M405533200.
M405533200 [pii] - Daniel T, Carling D (2002) Functional analysis
of mutations in the gamma 2 subunit of
AMP-activated protein kinase associated with
cardiac hypertrophy and Wolff-Parkinson-
White syndrome. J Biol Chem 277
(52):51017–51024. https://doi.org/10.
1074/jbc.M207093200. M207093200 [pii] - Zou L, Shen M, Arad M, He H, Lofgren B,
Ingwall JS, Seidman CE, Seidman JG, Tian R
(2005) N488I mutation of the gamma2-
subunit results in bidirectional changes in
AMP-activated protein kinase activity. Circ
Res 97(4):323–328. https://doi.org/10.
1161/01.RES.0000179035.20319.c2. 01.
RES.0000179035.20319.c2 [pii] - Kelly BP, Russell MW, Hennessy JR, Ensing GJ
(2009) Severe hypertrophic cardiomyopathy in
an infant with a novel PRKAG2 gene mutation:
potential differences between infantile and
adult onset presentation. Pediatr Cardiol 30
(8):1176–1179. https://doi.org/10.1007/
s00246-009-9521-3- Yogasundaram H, Paterson ID, Graham M,
Sergi C, Oudit GY (2016) Glycogen storage
disease because of a PRKAG2 mutation causing
severe biventricular hypertrophy and high-
grade atrio-ventricular block. Circ Heart Fail
9(8):pii: e003367.https://doi.org/10.1161/
circheartfailure.116.003367 - Sternick EB, Oliva A, Gerken LM,
Magalhaes L, Scarpelli R, Correia FS, Rego S,
Santana O, Brugada R, Wellens HJ (2011)
Clinical, electrocardiographic, and electrophys-
iologic characteristics of patients with a fascicu-
loventricular pathway: the role of PRKAG2
mutation. Heart Rhythm 8(1):58–64.
https://doi.org/10.1016/j.hrthm.2010.09.
081. S1547-5271(10)01024-6 [pii] - Vaughan CJ, Hom Y, Okin DA, McDermott
DA, Lerman BB, Basson CT (2003) Molecular
genetic analysis of PRKAG2 in sporadic Wolff-
Parkinson-White syndrome. J Cardiovasc Elec-
trophysiol 14(3):263–268 - Light PE, Wallace CH, Dyck JR (2003) Con-
stitutively active adenosine monophosphate-
activated protein kinase regulates voltage-
gated sodium channels in ventricular myocytes.
Circulation 107(15):1962–1965.https://doi.
org/10.1161/01.CIR.0000069269.60167.
02. 01.CIR.0000069269.60167.02 [pii] - Back Sternick E, de Almeida Araujo S, Ribeiro
da Silva Camargos E, Brasileiro Filho G (2016)
Atrial pathology findings in a patient with
PRKAG2 cardiomyopathy and persistent atrial
fibrillation. Circ Arrhythm Electrophysiol 9
(12):e004455. https://doi.org/10.1161/cir
cep.116.004455 - Schott JJ, Alshinawi C, Kyndt F, Probst V,
Hoorntje TM, Hulsbeek M, Wilde AA,
Escande D, Mannens MM, Le Marec H
(1999) Cardiac conduction defects associate
with mutations in SCN5A. Nat Genet 23
(1):20–21.https://doi.org/10.1038/12618 - McNair WP, Ku L, Taylor MR, Fain PR,
Dao D, Wolfel E, Mestroni L (2004) SCN5A
mutation associated with dilated cardiomyopa-
thy, conduction disorder, and arrhythmia. Cir-
culation 110(15):2163–2167. https://doi.
org/10.1161/01.cir.0000144458.58660.bb - Fatkin D, MacRae C, Sasaki T, Wolff MR,
Porcu M, Frenneaux M, Atherton J, Vidaillet
HJ Jr, Spudich S, De Girolami U, Seidman JG,
Seidman C, Muntoni F, Muehle G, Johnson W,
McDonough B (1999) Missense mutations in
the rod domain of the lamin A/C gene as
causes of dilated cardiomyopathy and
conduction-system disease. N Engl J Med
616 Arash Yavari et al.